1. Home
  2. RAYA vs FGEN Comparison

RAYA vs FGEN Comparison

Compare RAYA & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$4.20

Market Cap

4.2M

ML Signal

HOLD

Logo FibroGen Inc

FGEN

FibroGen Inc

HOLD

Current Price

$8.43

Market Cap

35.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAYA
FGEN
Founded
2019
1993
Country
China
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
35.6M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
RAYA
FGEN
Price
$4.20
$8.43
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$146.50
AVG Volume (30 Days)
32.8K
41.3K
Earning Date
04-17-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
53.38
Revenue
$27,101,325.00
$8,298,000.00
Revenue This Year
$20.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.16
Revenue Growth
18.78
N/A
52 Week Low
$3.13
$4.85
52 Week High
$736.99
$21.94

Technical Indicators

Market Signals
Indicator
RAYA
FGEN
Relative Strength Index (RSI) 49.89 44.02
Support Level $3.95 $8.30
Resistance Level $4.50 $10.47
Average True Range (ATR) 0.46 0.61
MACD -0.02 0.06
Stochastic Oscillator 27.92 17.34

Price Performance

Historical Comparison
RAYA
FGEN

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Share on Social Networks: